These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7534459)
21. Forskolin inhibits histamine release by neurotensin in the rat perfused hind limb. Kérouac R; St-Pierre S; Rioux F Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):309-12. PubMed ID: 6207575 [TBL] [Abstract][Full Text] [Related]
22. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523 [TBL] [Abstract][Full Text] [Related]
23. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs. Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515 [TBL] [Abstract][Full Text] [Related]
25. [Inhibition of 3', 5'-cyclic AMP phosphodiesterase in the guinea pig lung by a new anti-allergic: 10-(3-quinuclidinylmethyl) phenothiazine (LM 209)]. Uzan A; Le Fur G Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):160-8. PubMed ID: 178283 [TBL] [Abstract][Full Text] [Related]
26. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals. Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286 [TBL] [Abstract][Full Text] [Related]
27. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation. Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238 [TBL] [Abstract][Full Text] [Related]
28. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells]. Takahashi K; Shono T; Arai Y Arerugi; 1986 Oct; 35(10):1028-36. PubMed ID: 2434065 [No Abstract] [Full Text] [Related]
29. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). II. A lack of correlation between inhibition of mediator release and levels of cyclic AMP. Coutts SM; Khandwala A; Weinryb I Int Arch Allergy Appl Immunol; 1983; 70(4):303-10. PubMed ID: 6186609 [TBL] [Abstract][Full Text] [Related]
30. [The effect of the benzimidazole derivative AR-L 115 BS on the activities of myocardial adenylate cyclase and phosphodiesterase preparations (author's transl)]. Schuhmacher P; Greeff K; Noack E Arzneimittelforschung; 1982; 32(1):80-2. PubMed ID: 6277343 [TBL] [Abstract][Full Text] [Related]
31. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357 [TBL] [Abstract][Full Text] [Related]
32. Current views of the mechanism of action of prophylactic antiallergic drugs. González Alvarez R; Arruzazabala ML Allergol Immunopathol (Madr); 1981; 9(6):501-8. PubMed ID: 6122370 [TBL] [Abstract][Full Text] [Related]
33. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Kumari M; Cover PO; Poyser RH; Buckingham JC Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387 [TBL] [Abstract][Full Text] [Related]
34. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
35. Antiallergic activity profile in vitro of RHC 2963 and related compounds. Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298 [TBL] [Abstract][Full Text] [Related]